Print
15 March 2017
GMP News
Vasily Osmakov, Deputy Minister of Industry and Trade of the Russian Federation, held a meeting to discuss the support measures for manufacturers of equipment that can be used in the pharmaceutical industry.
To achieve these goals, Russian companies can benefit from a wide range of existing state support measures described by Vasily Osmakov during the meeting.
First of all this includes the preferential loans from the Industrial Development Fund issued for the projects related to implementation of new technologies or establishment of import substitution industries. In addition, Russian enterprises are provided with subsidies to compensate a part of their R&D costs (Decree of the Government of the Russian Federation No. 1312), as well as the subsidies to pay for the interest on loans in the amount of 0.7 of the key rate of the Bank of Russia (Decree of the Government of the Russian Federation No. 3), said Vasily Osmakov at the meeting.
He urged the manufacturers of equipment to actively join these and other state support programs, as well as to formulate their proposals for the development of Russian pharmaceutical engineering industry.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.